Virtus ETF Advisers’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-11,393
Closed -$343K 634
2024
Q4
$343K Sell
11,393
-8,258
-42% -$249K 0.14% 209
2024
Q3
$460K Hold
19,651
0.21% 187
2024
Q2
$350K Buy
19,651
+14,836
+308% +$264K 0.17% 199
2024
Q1
$73.2K Sell
4,815
-328
-6% -$4.99K 0.04% 403
2023
Q4
$87.8K Buy
5,143
+1,509
+42% +$25.8K 0.06% 409
2023
Q3
$30.4K Sell
3,634
-367
-9% -$3.07K 0.02% 428
2023
Q2
$99.4K Sell
4,001
-7,053
-64% -$175K 0.06% 384
2023
Q1
$166K Sell
11,054
-4,254
-28% -$64K 0.09% 316
2022
Q4
$181K Sell
15,308
-11,827
-44% -$140K 0.09% 322
2022
Q3
$161K Buy
27,135
+200
+0.7% +$1.19K 0.06% 343
2022
Q2
$114K Buy
26,935
+16,994
+171% +$71.9K 0.04% 399
2022
Q1
$95K Sell
9,941
-595
-6% -$5.69K 0.04% 311
2021
Q4
$200K Buy
10,536
+4,987
+90% +$94.7K 0.08% 210
2021
Q3
$185K Sell
5,549
-291
-5% -$9.7K 0.08% 290
2021
Q2
$227K Sell
5,840
-1,028
-15% -$40K 0.09% 256
2021
Q1
$331K Buy
6,868
+125
+2% +$6.02K 0.14% 222
2020
Q4
$351K Sell
6,743
-11,178
-62% -$582K 0.15% 169
2020
Q3
$480K Sell
17,921
-2,461
-12% -$65.9K 0.25% 141
2020
Q2
$397K Sell
20,382
-15,224
-43% -$297K 0.19% 199
2020
Q1
$350K Sell
35,606
-5,183
-13% -$50.9K 0.14% 208
2019
Q4
$453K Buy
40,789
+5,986
+17% +$66.5K 0.07% 216
2019
Q3
$195K Sell
34,803
-1,938
-5% -$10.9K 0.04% 256
2019
Q2
$318K Sell
36,741
-17,202
-32% -$149K 0.07% 200
2019
Q1
$434K Sell
53,943
-7,614
-12% -$61.3K 0.92% 33
2018
Q4
$252K Buy
61,557
+27,134
+79% +$111K 0.04% 157
2018
Q3
$193K Sell
34,423
-24,599
-42% -$138K 0.02% 194
2018
Q2
$776K Sell
59,022
-30,898
-34% -$406K 0.69% 47
2018
Q1
$1.28M Buy
89,920
+48,087
+115% +$683K 1.11% 13
2017
Q4
$343K Buy
41,833
+12,380
+42% +$102K 0.43% 102
2017
Q3
$349K Buy
29,453
+2,694
+10% +$31.9K 0.05% 122
2017
Q2
$269K Sell
26,759
-29,783
-53% -$299K 0.04% 138
2017
Q1
$659K Buy
56,542
+5,420
+11% +$63.2K 0.12% 88
2016
Q4
$238K Buy
51,122
+15,825
+45% +$73.7K 0.07% 156
2016
Q3
$273K Hold
35,297
0.13% 108
2016
Q2
$214K Buy
35,297
+11,311
+47% +$68.6K 0.16% 129
2016
Q1
$204K Buy
+23,986
New +$204K 0.28% 79